FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.
Earnings for FDC Limited (FDC.NS)
Earnings in 2023 (TTM): $46.94 M
According to FDC Limited's latest financial reports the company's current earnings (TTM) are $46.94 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of FDC Limited
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $46.94 M | $36.16 M |
| 2022 | $30.54 M | $22.99 M |
| 2021 | $34.29 M | $25.64 M |
| 2020 | $45.94 M | $35.7 M |
| 2019 | $37.91 M | $28.42 M |
| 2018 | $28.04 M | $20.12 M |
| 2017 | $28.51 M | $20.56 M |
| 2016 | $29.84 M | $22.34 M |
| 2015 | $26.06 M | $18.56 M |
| 2014 | $24.13 M | $17.55 M |
| 2013 | $25.87 M | $16.03 M |
| 2012 | $23.43 M | $18.38 M |
| 2011 | $20.4 M | $15.89 M |
| 2010 | $20.78 M | $17.88 M |
| 2009 | $21.4 M | $17.67 M |
| 2008 | $12.8 M | $10.21 M |
| 2007 | $8.92 M | $7.48 M |
| 2006 | $9.85 M | $7.77 M |
| 2005 | $10.06 M | $8.28 M |
| 2004 | $8.33 M | $6.51 M |